Welcome to our dedicated page for Kraig Biocraft Laboratories news (Ticker: $KBLB), a resource for investors and traders seeking the latest updates and insights on Kraig Biocraft Laboratories stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kraig Biocraft Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kraig Biocraft Laboratories's position in the market.
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces the addition of Dr. Nirmal Kumar, an expert in sericulture, to oversee spring production trials and launch of BAM-1 hybrid in Vietnam. Dr. Kumar's extensive experience in silkworm breeding and rearing brings valuable expertise to the Company's operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces senior management's travel to Vietnam to oversee spring production trials for recombinant spider silk. The Company aims for large-scale production, scouting production partners, and finalizing agreements for growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.55%
Tags
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) announces the preparation of a second business investment application in Vietnam to expand its operations. The company plans to submit the license application this month, in collaboration with Lam Dong Agro-Forestry Research and Experiment Center and Vietnam Sericulture Association. The new subsidiary, Prodigy Silk, will focus on advancing sericulture using the company's silk technology. The facility in Lam Dong Province is undergoing renovations for spring production trials, with CEO Kim Thompson emphasizing the strategic importance of this investment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.94%
Tags
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. achieves homozygosity for spider silk gene in parental strains for new BAM 1 hybrid production system, marking a significant milestone in commercializing recombinant spider silk technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces the creation of a premium yarn blending recombinant spider silk with Pima Cotton, showcasing vertical integration in textile markets. The company aims to target luxury apparel markets and expand into technical applications for spider silk materials.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces the opening of a new recombinant spider silk production center in Vietnam. The facility will support the Company's growing silk production in 2024 and enhance collaboration with the Vietnam Sericulture Association and Lam Dong Agro-Forestry Research and Experiment Center.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) has successfully created a new recombinant spider silk hybrid, BAM 1, resulting from careful selective breeding. This hybrid is expected to be the most efficient spider silk production system to date, producing more usable silk per cocoon. The company's technology utilizes enhanced silkworms to produce recombinant spider silk, with plans to transition into operations in the first and second quarters of 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. signs a key Memorandum of Understanding with the Vietnam Sericulture Association and the Lam Dong Agro-Forestry Research Experiment Center to enhance and expand silk production in Vietnam. The collaboration aims to commercialize advanced fiber production and achieve metric-ton production of spider silk in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) provides an update on the near-term commercial applications and opportunities for its recombinant spider silk, Dragon Silk™. The company is ramping up production trials and targeting end-product applications in fashion, performance apparel, engineering textiles, composites, cosmetics, defensive and protective textiles, bio-plastics, fiber optics, and medical textiles. It aims to achieve partial vertical integration in early spider silk products to maximize market position.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) announces its Vietnamese subsidiary, Prodigy Textiles, joining the Vietnam Sericulture Association to support silk production growth. The Company plans to expand recombinant spider silk production in 2024, aiming to contribute to Vietnam's global leadership in silk production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.25%
Tags
Kraig Biocraft Laboratories, Inc.
OTC:KBLB
KBLB Rankings
KBLB Stock Data
85.41M
776.63M
25.21%
Other Chemical and Fertilizer Mineral Mining
Mining, Quarrying, and Oil and Gas Extraction
United States of America
Ann Arbor
About KBLB
kraig biocraft laboratories, inc. (trading symbol: kblb) is a fully reporting biotechnology company focused on the development and commercialization of spider silks. as a reporting company, our annual and quarterly reports to the sec can be found on edgar and on this website. our investments in genetic research are targeted for product development and innovative near-term solutions to meet the practical problems of our world. our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. we are moving rapidly to commercialize of our spider silk technology, which we believe will have a significant impact on the global textiles industry. at the same time we are continuing to work in cooperation with leading laboratories to create new stronger and more flexible spider silk based fibers with potentially broad appli